Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality

Transjugular intrahepatic portosystemic shunt (TIPS) efficiently treats complications of portal hypertension. Liver and spleen stiffness might predict clinically significant portal hypertension. This prospective study investigated liver stiffness in patients receiving TIPS regardless of indication. Of 83 included patients, 16 underwent transient elastography immediately before and 30 minutes after TIPS (acute group), while 67 received shear wave elastography of liver and spleen 1 day before and 7 days after TIPS (chronic group) and were followed further. In blood samples obtained before TIPS from cubital, portal, and hepatic veins, levels of several interleukins (IL1b, IL6, IL8, IL10, IL18) and interferon‐gamma were analyzed. In 27 patients (5 acute, 22 chronic), it resulted in an increase in liver stiffness of >10%. In 56 patients, liver stiffness decreased or remained unchanged (<10%). Importantly, spleen stiffness measured by shear wave elastography decreased in all patients (chronic group). None of the clinical or laboratory parameters differed between patients with increase in liver stiffness and those without. Of note, patients with increased liver stiffness showed higher overall and/or hepatic venous levels of proinflammatory cytokines at TIPS and higher incidence of organ failure and worse survival after TIPS. C‐reactive protein values and increase of >10% in liver stiffness after TIPS were the only independent predictors of mortality in these patients. Conclusion: This study demonstrates that the presence of systemic inflammation predisposes patients to develop increased liver stiffness after TIPS, a predictor of organ failure and death. (NCT03072615) (Hepatology 2018;67:1472‐1484).

[1]  Hao Han,et al.  Point Shear Wave Elastography to Evaluate and Monitor Changing Portal Venous Pressure in Patients with Decompensated Cirrhosis. , 2017, Ultrasound in medicine & biology.

[2]  C. Strassburg,et al.  High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal , 2017, PloS one.

[3]  C. Strassburg,et al.  Shear‐wave elastography of the liver and spleen identifies clinically significant portal hypertension: A prospective multicentre study , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[4]  J. Trebicka.  Emergency TIPS in a Child-Pugh B patient: When does the window of opportunity open and close? , 2017, Journal of hepatology.

[5]  D. Thabut,et al.  Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites. , 2017, Gastroenterology.

[6]  S. Mueller.  Does pressure cause liver cirrhosis? The sinusoidal pressure hypothesis , 2016, World journal of gastroenterology.

[7]  S. Mueller,et al.  Primary liver injury and delayed resolution of liver stiffness after alcohol detoxification in heavy drinkers with the PNPLA3 variant I148M , 2016, World journal of hepatology.

[8]  Richard Moreau,et al.  Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failure , 2016, Hepatology.

[9]  P. Blanke,et al.  Free Hepatic Vein Pressure Is Not Useful to Calculate the Portal Pressure Gradient in Cirrhosis: A Morphologic and Hemodynamic Study. , 2016, Journal of vascular and interventional radiology : JVIR.

[10]  J. Trebicka.  Predisposing Factors in Acute-on-Chronic Liver Failure , 2016, Seminars in Liver Disease.

[11]  J. Trebicka,et al.  Sequential shear-wave elastography of liver and spleen rules out clinically significant portal hypertension in compensated advanced chronic liver disease , 2016, Gut.

[12]  C. Trautwein,et al.  Chemokine (C‐X‐C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[13]  S. Mueller,et al.  Arterial pressure suffices to increase liver stiffness. , 2015, American journal of physiology. Gastrointestinal and liver physiology.

[14]  R. Franchis.  Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension , 2015 .

[15]  R. Fimmers,et al.  Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy. , 2015, Gastroenterology.

[16]  M. Karsdal,et al.  Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS , 2015, Digestive Diseases and Sciences.

[17]  Asociacion Latinoamericana para el Estudio del Higado.  EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. , 2015, Journal of hepatology.

[18]  J. Bosch,et al.  Real-time shear-wave elastography: applicability, reliability and accuracy for clinically significant portal hypertension. , 2015, Journal of hepatology.

[19]  M. Ronot,et al.  Prospective comparison of spleen and liver stiffness by using shear-wave and transient elastography for detection of portal hypertension in cirrhosis. , 2015, Radiology.

[20]  M. Langer,et al.  Effect of TIPS placement on portal and splanchnic arterial blood flow in 4-dimensional flow MRI , 2015, European Radiology.

[21]  R. Moreau,et al.  The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure. , 2015, Journal of hepatology.

[22]  J. Rubin,et al.  Sonographic Assessment of Spleen Stiffness Before and After Transjugular Intrahepatic Portosystemic Shunt Placement With or Without Concurrent Embolization of Portal Systemic Collateral Veins in Patients With Cirrhosis and Portal Hypertension , 2015, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[23]  R. Jalan,et al.  Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol‐related acute‐on‐chronic liver failure , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[24]  S. Bota,et al.  New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[25]  R. Fimmers,et al.  CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt. , 2015, Journal of hepatology.

[26]  R. de Franchis.  Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. , 2015, Journal of hepatology.

[27]  R. Moreau,et al.  Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. , 2014, Journal of hepatology.

[28]  W. Jeong,et al.  Shear-wave elastography: a noninvasive tool for monitoring changing hepatic venous pressure gradients in patients with cirrhosis. , 2014, Radiology.

[29]  R. Fimmers,et al.  Soluble TNF-Alpha-Receptors I Are Prognostic Markers in TIPS-Treated Patients with Cirrhosis and Portal Hypertension , 2013, PloS one.

[30]  M. Rössle.  TIPS: 25 years later. , 2013, Journal of hepatology.

[31]  R. Moreau,et al.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. , 2013, Gastroenterology.

[32]  F. Lammert,et al.  Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis. , 2013, Journal of hepatology.

[33]  O H Gilja,et al.  EFSUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography.Part 2: Clinical Applications , 2013, Ultraschall in der Medizin.

[34]  F. Schaefer,et al.  EFSUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography. Part 1: Basic Principles and Technology , 2013, Ultraschall in der Medizin.

[35]  J. Bosch,et al.  Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. , 2013, Gastroenterology.

[36]  M. Trauner,et al.  Noninvasive screening for liver fibrosis and portal hypertension by transient elastography—a large single center experience , 2012, Wiener klinische Wochenschrift.

[37]  M. Büchler,et al.  Transient elastography with the XL probe rapidly identifies patients with nonhepatic ascites , 2012, Hepatic medicine : evidence and research.

[38]  T. Reiberger,et al.  Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis , 2012, Journal of Gastroenterology.

[39]  F. Tacke,et al.  Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU , 2011, Critical care.

[40]  T. Sauerbruch,et al.  Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt , 2011, European journal of gastroenterology & hepatology.

[41]  F. Nevens,et al.  Early use of TIPS in patients with cirrhosis and variceal bleeding. , 2010, The New England journal of medicine.

[42]  L. Sandrin,et al.  Liver stiffness: a novel parameter for the diagnosis of liver disease , 2010, Hepatic medicine : evidence and research.

[43]  Gunda Millonig,et al.  Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. , 2010, World journal of gastroenterology.

[44]  Gunda Millonig,et al.  Liver stiffness is directly influenced by central venous pressure. , 2010, Journal of hepatology.

[45]  J. Bosch,et al.  The clinical use of HVPG measurements in chronic liver disease , 2009, Nature Reviews Gastroenterology &Hepatology.

[46]  M. Ziol,et al.  Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol‐related cirrhosis , 2008, Alimentary pharmacology & therapeutics.

[47]  Gunda Millonig,et al.  Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis , 2008, Hepatology.

[48]  Ze-Zhou Song.  Acute viral hepatitis increases liver stiffness values measured by transient elastography , 2008, Hepatology.

[49]  J M Peron,et al.  Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease , 2008, Alimentary pharmacology & therapeutics.

[50]  Giacomo Belli,et al.  Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis , 2007, Hepatology.

[51]  P. Kamath,et al.  A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts , 2000, Hepatology.